NEW YORK (GenomeWeb News) – Molecular Devices today announced a global distribution agreement with Fluxion Biosciences covering its IonFlux instruments and consumables.
Molecular Devices also is providing support for all IonFlux Systems users as part of the deal, it said.
Financial and other terms of the deal were not disclosed.
South San Francisco, Calif.-based Fluxion provides tools for cellular analysis. Its portfolio includes instruments for live cell imaging and the analysis of circulating tumor cells. The Ion Flux is for automated patch clamping.
Sunnyvale, Calif.-based Molecular Devices is a Danaher company and provides bioanalytical measurement systems, software, and consumables, including products for high-throughput screening, and genomic and cellular analysis.